BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 24744588)

  • 1. HLA variants related to primary sclerosing cholangitis influence rejection after liver transplantation.
    Fosby B; Næss S; Hov JR; Traherne J; Boberg KM; Trowsdale J; Foss A; Line PD; Franke A; Melum E; Scott H; Karlsen TH
    World J Gastroenterol; 2014 Apr; 20(14):3986-4000. PubMed ID: 24744588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis.
    Patel YA; Henson JB; Wilder JM; Zheng J; Chow SC; Berg CL; Knechtle SJ; Muir AJ
    Clin Transplant; 2018 Oct; 32(10):e13388. PubMed ID: 30136315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C.
    Hov JR; Lleo A; Selmi C; Woldseth B; Fabris L; Strazzabosco M; Karlsen TH; Invernizzi P
    J Hepatol; 2010 May; 52(5):712-7. PubMed ID: 20347497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Leukocyte Antigen-C Genotype and Killer Immunoglobulin-like Receptor-Ligand Matching in Korean Living Donor Liver Transplantation.
    Lee H; Park KH; Park HS; Ryu JH; Lim J; Kim Y; Na GH; Kim DG; Oh EJ
    Ann Lab Med; 2017 Jan; 37(1):45-52. PubMed ID: 27834065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis.
    Karlsen TH; Boberg KM; Olsson M; Sun JY; Senitzer D; Bergquist A; Schrumpf E; Thorsby E; Lie BA
    J Hepatol; 2007 May; 46(5):899-906. PubMed ID: 17383044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor with HLA-C2 is associated with acute rejection following liver transplantation in Southern Chinese.
    Chen R; Yi H; Zhen J; Fan M; Xiao L; Yu Q; Yang Z; Ning L; Deng Z; Chen G
    HLA; 2022 Aug; 100(2):133-141. PubMed ID: 35509131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
    Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
    Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.
    Legaz I; López-Álvarez MR; Campillo JA; Moya-Quiles MR; Bolarín JM; de la Peña J; Salgado G; Gimeno L; García-Alonso AM; Muro M; Miras M; Alonso C; Álvarez-López MR; Minguela A
    Transplantation; 2013 Apr; 95(8):1037-44. PubMed ID: 23478359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with
    Bajer L; Slavcev A; Macinga P; Sticova E; Brezina J; Roder M; Janousek R; Trunecka P; Spicak J; Drastich P
    World J Gastroenterol; 2018 Nov; 24(43):4939-4949. PubMed ID: 30487703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor and recipient HLA/KIR genotypes do not predict liver transplantation outcome.
    Moroso V; van der Meer A; Tilanus HW; Kazemier G; van der Laan LJ; Metselaar HJ; Joosten I; Kwekkeboom J
    Transpl Int; 2011 Sep; 24(9):932-42. PubMed ID: 21672051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.
    Alexander J; Lord JD; Yeh MM; Cuevas C; Bakthavatsalam R; Kowdley KV
    Liver Transpl; 2008 Feb; 14(2):245-51. PubMed ID: 18236405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of donor and recipient KIR genes and KIR ligands on the occurrence of acute graft-versus-host disease and graft survival after HLA-identical sibling hematopoietic stem cell transplantation.
    Hoseinian SA; Jafari D; Mahmoodi M; Alimoghaddam K; Ostadali M; Talebzadeh Bonakdar A; Foma AM; Yekaninejad MS; Amirzargar AA
    Turk J Med Sci; 2018 Aug; 48(4):794-804. PubMed ID: 30119155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation.
    Symons HJ; Leffell MS; Rossiter ND; Zahurak M; Jones RJ; Fuchs EJ
    Biol Blood Marrow Transplant; 2010 Apr; 16(4):533-42. PubMed ID: 19961944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-C matching and liver transplants: donor-recipient genotypes influence early outcome and CD8+KIR2D+ T-cells recuperation.
    López-Alvarez MR; Moya-Quiles MR; Minguela A; Gil J; Miras M; Campillo JA; Díaz-Alderete MA; García-Alonso AM; Sánchez-Bueno F; Vicario JL; Muro M; Alvarez-López MR
    Transplantation; 2009 Aug; 88(3 Suppl):S54-61. PubMed ID: 19667963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Killer cell immunoglobulin-like receptor polymorphisms in HLA-identical kidney transplant recipients: lack of 2DL2 and 2DS2 may be associated with poor graft function.
    Cirocco RE; Mathew JM; Burke GW; Esquenazi V; Miller J
    Tissue Antigens; 2007 Apr; 69 Suppl 1():123-4. PubMed ID: 17445184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
    Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
    Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leucocyte antigens and pediatric autoimmune liver disease: diagnosis and prognosis.
    Junge N; Tiedau M; Verboom M; Hallensleben M; Blasczyk R; Schlue J; Goldschmidt I; Pfister ED; Baumann U
    Eur J Pediatr; 2016 Apr; 175(4):527-37. PubMed ID: 26567543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.